Zobrazeno 1 - 1
of 1
pro vyhledávání: ''
Autor:
Corbeil G, Pavel Hamet, Kren, Ludmila Kazdova, Ondrej Seda, Sedová L, Johanne Tremblay, Krenová D, Oliyarnyk O
Publikováno v:
Pharmacogenomics. 9:141-155
Introduction: Thiazolidinediones are increasingly used drugs for the treatment of Type 2 diabetes. The individual response to thiazolidinedione therapy, ranging from the variable degree of metabolic improvement to harmful side-effects, is empirical,